Schnell O - Search Results

1

Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas.

Grasbon-Frodl EM, Kreth FW, Ruiter M, Schnell O, Bise K, Felsberg J, Reifenberger G, Tonn JC, Kretzschmar HA. Grasbon-Frodl EM, et al. Among authors: schnell o. Int J Cancer. 2007 Dec 1;121(11):2458-64. doi: 10.1002/ijc.23020. Int J Cancer. 2007. PMID: 17691113

2

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly.

Reifenberger G, Hentschel B, Felsberg J, Schackert G, Simon M, Schnell O, Westphal M, Wick W, Pietsch T, Loeffler M, Weller M; German Glioma Network. Reifenberger G, et al. Among authors: schnell o. Int J Cancer. 2012 Sep 15;131(6):1342-50. doi: 10.1002/ijc.27385. Epub 2012 Jan 11. Int J Cancer. 2012. PMID: 22139906

3

Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature.

Schnell O, Krebs B, Wagner E, Romagna A, Beer AJ, Grau SJ, Thon N, Goetz C, Kretzschmar HA, Tonn JC, Goldbrunner RH. Schnell O, et al. Brain Pathol. 2008 Jul;18(3):378-86. doi: 10.1111/j.1750-3639.2008.00137.x. Epub 2008 Apr 2. Brain Pathol. 2008. PMID: 18394009 Free PMC article.

4

Krüppel-like factor 8 (KLF8) is expressed in gliomas of different WHO grades and is essential for tumor cell proliferation.

Schnell O, Romagna A, Jaehnert I, Albrecht V, Eigenbrod S, Juerchott K, Kretzschmar H, Tonn JC, Schichor C. Schnell O, et al. PLoS One. 2012;7(1):e30429. doi: 10.1371/journal.pone.0030429. Epub 2012 Jan 19. PLoS One. 2012. PMID: 22276196 Free PMC article.

5

ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients.

Adam SA, Schnell O, Pöschl J, Eigenbrod S, Kretzschmar HA, Tonn JC, Schüller U. Adam SA, et al. Among authors: schnell o. Brain Pathol. 2012 Nov;22(6):788-97. doi: 10.1111/j.1750-3639.2012.00592.x. Epub 2012 Apr 19. Brain Pathol. 2012. PMID: 22417385 Free PMC article.

6

FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status.

Niyazi M, Schnell O, Suchorska B, Schwarz SB, Ganswindt U, Geisler J, Bartenstein P, Kreth FW, Tonn JC, Eigenbrod S, Belka C, la Fougère C. Niyazi M, et al. Among authors: schnell o. Radiother Oncol. 2012 Jul;104(1):78-82. doi: 10.1016/j.radonc.2012.04.022. Epub 2012 Jun 5. Radiother Oncol. 2012. PMID: 22673727

7

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.

Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, Hau P, Herrlinger U, Sabel MC, Wirsching HG, Ketter R, Bähr O, Platten M, Tonn JC, Schlegel U, Marosi C, Goldbrunner R, Stupp R, Homicsko K, Pichler J, Nikkhah G, Meixensberger J, Vajkoczy P, Kollias S, Hüsing J, Reifenberger G, Wick W; DIRECTOR Study Group. Weller M, et al. Among authors: schnell o. Clin Cancer Res. 2015 May 1;21(9):2057-64. doi: 10.1158/1078-0432.CCR-14-2737. Epub 2015 Feb 5. Clin Cancer Res. 2015. PMID: 25655102 Free article. Clinical Trial.

8

Chemotherapy for intracranial ependymoma in adults.

Gramatzki D, Roth P, Felsberg J, Hofer S, Rushing EJ, Hentschel B, Westphal M, Krex D, Simon M, Schnell O, Wick W, Reifenberger G, Weller M. Gramatzki D, et al. Among authors: schnell o. BMC Cancer. 2016 Apr 23;16:287. doi: 10.1186/s12885-016-2323-0. BMC Cancer. 2016. PMID: 27108407 Free PMC article.

9

MGMT promoter methylation is not correlated with integrin expression in malignant gliomas: clarifying recent clinical trial results.

Schnell O, Albrecht V, Pfirrmann D, Eigenbrod S, Krebs B, Romagna A, Siller S, Giese A, Tonn JC, Schichor C. Schnell O, et al. Med Oncol. 2018 Jun 7;35(7):103. doi: 10.1007/s12032-018-1162-z. Med Oncol. 2018. PMID: 29882028

10

Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography.

Schnell O, Krebs B, Carlsen J, Miederer I, Goetz C, Goldbrunner RH, Wester HJ, Haubner R, Pöpperl G, Holtmannspötter M, Kretzschmar HA, Kessler H, Tonn JC, Schwaiger M, Beer AJ. Schnell O, et al. Neuro Oncol. 2009 Dec;11(6):861-70. doi: 10.1215/15228517-2009-024. Neuro Oncol. 2009. PMID: 19401596 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

337 results

Search Page